Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Feb 15;15(5):e00687. doi: 10.14309/ctg.0000000000000687

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 Takeda Pharmaceuticals USA, Inc. Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 3. — Constipation-related complications 6 months before prucalopride initiation (baseline period) and 6 months after prucalopride initiation (study period) in patients with CIC. All constipation-related complications for which at least 1 occurrence was recorded in all patients; no occurrence of perianal/perirectal abscess was recorded. P values for the change in constipation-related complications from baseline to 6 months after prucalopride initiation were calculated using McNemar tests. *P < 0.05, **P < 0.01, ***P < 0.001. CIC, chronic idiopathic constipation.